This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: P2d, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4 
1 out of 3,699 
Years Active: 2011-2014
Title: The Innovative Contributions of Tony Giordano
Introduction
Tony Giordano is a notable inventor based in Shreveport, Louisiana. He has made significant contributions to the field of pharmaceuticals, particularly through his work on thalidomide analogs. With a total of three patents to his name, Giordano's innovations are aimed at modulating tumor necrosis factor alpha (TNF-α) activity and angiogenesis.
Latest Patents
Giordano's latest patents focus on thalidomide analogs that have the potential to modulate TNF-α activity and angiogenesis. These analogs are particularly noteworthy as they are isosteric sulfur-containing compounds. The patents also disclose methods for treating subjects with these innovative analogs, showcasing their potential therapeutic applications.
Career Highlights
Throughout his career, Tony Giordano has worked with various organizations, including P2D, Inc. and the National Institutes of Health, which is a component of the U.S. Department of Health & Human Services. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Giordano has collaborated with esteemed colleagues such as Nigel H. Greig and Harold W. Holloway. These partnerships have likely enriched his research and led to further advancements in his field.
Conclusion
Tony Giordano's innovative work in developing thalidomide analogs demonstrates his commitment to advancing medical science. His contributions have the potential to impact treatment options for various conditions, highlighting the importance of his research in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile